Michael Craig Pine

Insider Reports History

Location
Watertown, MA
Signature
/s/ Ron Honig, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Craig Pine:

Company Role Class Num Shares Value Price $ Report Date Ownership
EyePoint Pharmaceuticals, Inc. Chief Corp Dev.&Strat. Officer Restricted Stock Units 30,570 $623,628 $20.40 06 Jan 2024 Direct
EyePoint Pharmaceuticals, Inc. Chief Corp Dev.&Strat. Officer Common Stock 13,662 $341,763 $25.02 06 Jan 2024 Direct
EyePoint Pharmaceuticals, Inc. Chief Corp Dev.&Strat. Officer Stock Option (Right to Buy) 42,000 05 Jan 2024 Direct

Insider Reports Filed by Michael Craig Pine

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EYPT EyePoint Pharmaceuticals, Inc. 05 Jan 2024 5 -$121,706 4 Chief Corp Dev.&Strat. Officer 09 Jan 2024, 21:11
EYPT EyePoint Pharmaceuticals, Inc. 04 Dec 2023 4 -$442,890 4/A Chief Corp Dev.&Strat. Officer 11 Dec 2023, 16:15
EYPT EyePoint Pharmaceuticals, Inc. 20 Jun 2023 1 $0 4 Chief Corp Dev.&Strat. Officer 22 Jun 2023, 09:16
EYPT EyePoint Pharmaceuticals, Inc. 25 May 2023 2 $0 4 Chief Corp Dev.&Strat. Officer 30 May 2023, 17:14
EYPT EyePoint Pharmaceuticals, Inc. 06 Jan 2023 1 $0 4 Chief Corp Dev.&Strat. Officer 10 Jan 2023, 16:51
EYPT EyePoint Pharmaceuticals, Inc. 14 Mar 2022 1 +$12,210 4 Chief Corp Dev.&Strat. Officer 15 Mar 2022, 16:21
EYPT EyePoint Pharmaceuticals, Inc. 10 Jan 2022 0 $0 3 Chief Corp Dev.&Strat. Officer 14 Jan 2022, 13:47
EYPT EyePoint Pharmaceuticals, Inc. 10 Jan 2022 1 $0 4 Chief Corp Dev.&Strat. Officer 14 Jan 2022, 13:14